Research field (6)：
Molecular biology
, Immunology
, Tumor biology
, Virology
, Laboratory animal science
, Experimental pathology
Research keywords (4)：
分子免疫学
, 分子腫瘍学
, 細胞生物学
, 分子生物学
Research theme for competitive and other funds (13)：
2021 - 2024 発症危険度を峻別する新規ATLバイオマーカーの同定と臨床検体における評価
2017 - 2021 ATLL及びB細胞性リンパ腫発症リスク評価・判定法の開発
2017 - 2019 Molecular and sero-epidemiologcal survey on the prevalence of human T-lymphotropic virus type 1 (HTLV-1), a causative agent of adult T-cell leukemia / lymphoma, in Sabah, Malaysia
2015 - 2018 Identification of ATLL-associated genes in Rapid ATLL model mouse
2016 - 2018 レクチンマイクロアレイを用いた食道癌の再発予測マーカーの開発
2013 - 2015 Linkage between the SNPs of TAX1BP1 complex and inflammatory diseases
2010 - 2012 Molecular pathological study on inflammatory cardiac valvulitis in TAX1BP1-deficient mice
2011 - レクチンアレイプロファイリングによるATL病型早期診断技術の構築
2006 - 新規トランスジェニックマウスによる初期腫瘍形成シグナル検出系の構築
2005 - ピンポイント分子標的・抗腫瘍ペプチドの開発
1996 - 1997 酵母を用いた時間生物学:生物時計と自食死の分子細胞生物学的解析
1993 - 1995 酵母における生物時計の遺伝学的,分子生物学的解析
1993 - 1993 酵母時計遺伝子の機能解析
Show all
Papers (78)：
Hidekatsu Iha. HTLV-1: Neglected Virus in Southeast Asia for Decades. Borneo Journal of Medical Sciences (BJMS). 2024. 18. 2
Haruka Sudo, Yasuhiro Tonoyama, Emi Ikebe, Hiroo Hasegawa, Hidekatsu Iha, Yo-Ichi Ishida. Proteomic analysis of adult T-cell leukemia/lymphoma: A biomarker identification strategy based on preparation and in-solution digestion methods of total proteins. Leukemia research. 2024. 138. 107454-107454
Tomonaga Ichikawa, Akira Suekane, Shingo Nakahata, Hidekatsu Iha, Kazuya Shimoda, Takashi Murakami, Kazuhiro Morishita. Inhibition of PRMT5/MEP50 Arginine Methyltransferase Activity Causes Cancer Vulnerability in NDRG2low Adult T-Cell Leukemia/Lymphoma. International journal of molecular sciences. 2024. 25. 5
Yu Wang, Shunsuke Shimosaki, Emi Ikebe, Hidekatsu Iha, Jun-ichi Yamamoto, Nichole Fife, Tomonaga Ichikawa, Mitsuo Hori, Masao Ogata, Yoshiyuki Tsukamoto, et al. IMiD/CELMoD-induced growth suppression of adult T-cell leukemia/lymphoma cells via cereblon through downregulation of target proteins and their downstream effectors. Frontiers in Oncology. 2024. 13
Yu Wang, Hidekatsu Iha. The Novel Link between Gene Expression Profiles of Adult T-Cell Leukemia/Lymphoma Patients' Peripheral Blood Lymphocytes and Ferroptosis Susceptibility. Genes. 2023. 14. 11
WANG Yu, OKITA Mizuho, OGATA Masao, HAGIWARA Shotaro, YASUI Hiroshi, UCHIMARU Kaoru, KOH Kiryan, UTSUNOMIYA Atae, WATANABE Toshiki, WATANABE Toshiki, et al. Identification and validation of the novel ATL biomarkers. 日本HTLV-1学会学術集会. 2023. 9th
池辺詠美, 池辺詠美, 松岡佐保子, 中島誠, 村岡弘美, 吉村千穂子, 山岸誠, 内丸薫, 伊波英克, 内丸薫, et al. Investigation of the usefulness of NAE inhibitors as novel ATL therapies. 日本HTLV-1学会学術集会. 2023. 9th
IHA Hidekatsu, IHA Hidekatsu, SABRI Shanaz Irwani Binti, KUGAN Omar Kwang, SHAHAROM Saliz Mazrina Binti, JEFFREE Mohammad Saffree, FORNACE Kimberly, MORI Daisuke, YAHIRO Takaaki, HAMAGUCHI Isao, et al. Serological survey for HTLV-1 infection in the Sabah state of Northern Borneo, Malaysia. 日本HTLV-1学会学術集会. 2023. 9th
T-Cell Leukemia - Characteristics, Treatment and Prevention
INTECH 2013
HTLV-1と疾患
文光堂 2007
Committee career (3)：
2023/07 - 現在 Frontiers in Microbiology (Virology) Associate Editor
2014/08 - 現在 日本HTLV-1学会 評議員
2008/04 - 2012/07 大分TLO 理事
Awards (2)：
2003 - NIH recognized employee award
2002 - NIH recognized employee award
Association Membership(s) (9)：
American Society for Microbiology
, THE JAPANESE ASSOCIATION FOR MOLECULAR TARGET THERAPY OF CANCER
, THE JAPANESE CANCER ASSOCIATION
, THE MOLECULAR BIOLOGY SOCIETY OF JAPAN
, 日本HTLV-1学会
, JAPANESE SOCIETY FOR IMMUNOLOGY (JSI)
, THE JAPANESE SOCIETY FOR VIROLOGY
, THE JAPANESE SOCIETY FOR COMPLEMENTARY AND ALTERNATIVE MEDICINE
, THE SOCIETY FOR BIOTECHNOLOGY, JAPAN
